Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Utility of Prenatal Whole Exome Sequencing

NCT03482141 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT03482141
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03482141 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Utility of Prenatal Whole Exome Sequencing
Lead sponsor
University of California, San Francisco
Phase
Not applicable
Overall status
Completed
Start date
August 1, 2017
Completion date
May 13, 2022
Enrollment
316 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac anomalies, central nervous system anomalies, gastrointestinal anomalies, genito-urinary anomalies, multiple anomalies, skeletal anomalies, structural anomalies, thorax anomalies